Teekay director sells 400 shares after exercise

A Teekay director exercised 400 options and sold 400 common shares in a same-day transaction.

Available on EDGAR 09/18/2026 - 04:26 PM EDT Accepted by SEC EDGAR 09/18/2026 - 04:25 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

TEEKAY CORP LTD (TK) director Heidi Simon Locke reported a same-day option exercise and share sale on September 17, 2026. She exercised 400 stock options for Common Stock at an exercise price of $5.81 per share, acquiring 400 shares, then sold 400 Common shares at a weighted average price of $14.93 per share. Following the transaction, she held 9,600 stock options directly, with an exercise price of $5.81 and an expiration date of June 7, 2033. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Exercise and Sale: 400 shares ($4K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Locke Simon Heidi

Role Director

Sold 400 shs ($6K)

Approx. gross sale proceeds $6K

Approx. exercise cost $2K

Approx. pre-tax spread $4K

Share of Position Sold 0.86%

Type	Security	Shares	Price	Value
Exercise	Stock Option ("Right to Buy")	400	$5.81	$2K
Exercise	Common Stock	400	$5.81	$2K
Sale	Common Stock F1	400	$14.93	$6K

Holdings After Transaction: Stock Option ("Right to Buy") — 9,600 contracts (Direct); Common Stock — 46,000.5095 shares (Direct)

Holdings Before and After: Stock Option ("Right to Buy"), 10,000 to 9,600 contracts (Direct); Common Stock, 46,000.5095 to 46,000.5095 shares (Direct)

Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (1)

1. F1. The transaction was executed in multiple trades all of which were at $14.93. The price reported above reflects the weighted average sale price.

Key Figures

Options exercised: 400 shares Exercise price: $5.81 per share Shares sold: 400 shares +3 more

6 metrics

Options exercised 400 shares Stock options exercised into Common Stock on September 17, 2026

Exercise price $5.81 per share Exercise price of Stock Option ("Right to Buy")

Shares sold 400 shares Common Stock sold on September 17, 2026

Weighted average sale price $14.93 per share Common Stock sale executed in multiple trades

Options held after transaction 9,600 options Stock options directly owned following the option exercise

Option expiration date June 7, 2033 Expiration of Stock Option ("Right to Buy")

Key Terms

Stock Option ("Right to Buy"), derivative security, weighted average sale price

3 terms

Stock Option ("Right to Buy") financial

"The security title is listed as Stock Option ("Right to Buy")."

derivative security financial

"Described as an exercise or conversion of derivative security."

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

weighted average sale price financial

"The price reported reflects the weighted average sale price."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Teekay (TK) director Heidi Simon Locke report?

She reported exercising 400 stock options for Common Stock at $5.81 per share and selling 400 Common shares at a weighted average price of $14.93 per share on September 17, 2026.

How many Teekay (TK) stock options does the director hold after this Form 4?

After the reported transactions, the director held 9,600 stock options directly, each with an exercise price of $5.81 and an expiration date of June 7, 2033.

At what prices were the Teekay (TK) transactions executed on September 17, 2026?

The stock options were exercised at an exercise price of $5.81 per share, and the resulting 400 Common shares were sold at a weighted average sale price of $14.93 per share based on multiple trades.

Were the reported Teekay (TK) insider trades under a Rule 10b5-1 plan?

No. The filing indicates that no Rule 10b5-1 trading plan is affirmed for the reported transactions.

What type of derivative security did the Teekay (TK) director exercise?

The director exercised a Stock Option ("Right to Buy") derivative security for 400 underlying shares of Common Stock at an exercise price of $5.81 per share, originally exercisable from June 7, 2023 and expiring on June 7, 2033.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Locke Simon Heidi

(Last) (First) (Middle)

C/O TEEKAY

2ND FL, SWAN BUILDING, 26 VICTORIA ST

(Street)

HAMILTON HM 12

(City) (State) (Zip)

BERMUDA

(Country)

2. Issuer Name and Ticker or Trading Symbol
TEEKAY CORP LTD [ TK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2026		M		400	A	$5.81	46,400.5095	D
Common Stock	09/17/2026		S		400	D	$14.93(1)	46,000.5095	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option ("Right to Buy")	$5.81	09/17/2026		M			400	06/07/2023	06/07/2033	Common Stock	400	$5.81	9,600	D

Explanation of Responses:

1. The transaction was executed in multiple trades all of which were at $14.93. The price reported above reflects the weighted average sale price.

Remarks:

	/s/ Heidi Locke Simon	09/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)